Interv Akut Kardiol. 2022;21(2):79-83 | DOI: 10.36290/kar.2022.013

Effect of precipitating factors and signs of acute heart failure on length of hospital stay

Jiří Dokoupil1, Juraj Hrečko1, Eva Čermáková2, Radek Pudil1
1 1st Department of Internal Medicine - Cardioangiology, Charles University, Faculty of Medicine and University Hospital in Hradec Králové
2 Department of Medical Biophysics, Faculty of Medicine in Hradec Králové, Charles University

Aim: We aimed to assess the impact of precipitating factors and signs of acute heart failure on the length of hospital stay according to the ejection fraction (EF) subgroups.

Methods: We conducted a retrospective study among acute heart failure patients hospitalized at the Department of Cardioangiology in 2017. The most frequent precipitants and signs were included in the multivariate analysis to assess their association with the length of hospital stay.

Results: We included 376 patients with a median length of hospital stay 11 days. There were 198, 58, and 120 patients with reduced, mildly reduced, and preserved EF, respectively. In reduced EF, peripheral swelling (OR 1.97, CI 1.02–3.78) and pulmonary congestion (OR 2.72, CI 1.38–5.34) were associated with a longer hospital stay. Non­‑pulmonary infection (OR 50.57, CI 2.82–906.84) and heart failure progression (OR 15.33, CI 1.25–188.53) were associated with a longer hospital stay in mildly reduced EF, and acute pulmonary disease was associated with a longer hospital stay in patients with mildly reduced (OR 10.77, CI 1.07–108.81) and preserved (OR 3.96, CI 1.05–14.99) EF.

Conclusion: Precipitating factors and signs of acute heart failure have different impacts on the length of hospital stay among patients with reduced, mildly reduced or preserved EF.

Keywords: acute heart failure, epidemiology, length of hospital stay, precipitating factors, signs of heart failure

Accepted: March 24, 2022; Prepublished online: March 24, 2022; Published: April 28, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dokoupil J, Hrečko J, Čermáková E, Pudil R. Effect of precipitating factors and signs of acute heart failure on length of hospital stay. Interv Akut Kardiol. 2022;21(2):79-83. doi: 10.36290/kar.2022.013.
Download citation

References

  1. Virani SS, Alonso A, Aparicio HJ, et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143:e254-e743. Go to original source... Go to PubMed...
  2. Lesyuk W, Kriza C, Kolominsky­‑Rabas P. Cost­‑of­‑illness studies in heart failure: a systematic review 2004-2016. BMC Cardiovasc Disord. 2018;18:74. Go to original source... Go to PubMed...
  3. Arrigo M, Gayat E, Parenica J, et al. Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry. Eur J Heart Fail. 2017;19:201-8. Go to original source... Go to PubMed...
  4. Arrigo M, Tolppanen H, Sadoune M, et al. Effect of precipitating factors of acute heart failure on readmission and long-term mortality. ESC Heart Fail. 2016;3:115-21. Go to original source... Go to PubMed...
  5. Verdu­‑Rotellar JM, Vaillant­‑Roussel H, Abellana R, et al. Precipitating factors of heart failure decompensation, short­‑term morbidity and mortality in patients attended in primary care. Scand J Prim Health Care. 2020;38:473-80. Go to original source... Go to PubMed...
  6. Platz E, Jhund PS, Claggett BL, et al. Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality: Precipitants of heart failure hospitalization. Eur J Heart Fail. 2018;20:295-303. Go to original source... Go to PubMed...
  7. Chernomordik F, Berkovitch A, Schwammenthal E, et al. Short- and Long­‑Term Prognostic Implications of Jugular Venous Distension in Patients Hospitalized With Acute Heart Failure. Am J Cardiol. 2016;118:226-31. Go to original source... Go to PubMed...
  8. Oliva F, Mortara A, Cacciatore G, et al. Acute heart failure patient profiles, management and in­‑hospital outcome: results of the Italian Registry on Heart Failure Outcome. Eur J Heart Fail. 2012;14:1208-17. Go to original source... Go to PubMed...
  9. Yancy CW, Lopatin M, Stevenson LW, et al. Clinical Presentation, Management, and In­‑Hospital Outcomes of Patients Admitted With Acute Decompensated Heart Failure With Preserved Systolic Function. J Am Coll Cardiol. 2006;47:76-84. Go to original source... Go to PubMed...
  10. Chioncel O, Mebazaa A, Maggioni AP, et al. Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry. Eur J Heart Fail. 2019;21:1338-52. Go to original source... Go to PubMed...
  11. Yaku H, Ozasa N, Morimoto T, et al. Demographics, Management, and In­‑Hospital Outcome of Hospitalized Acute Heart Failure Syndrome Patients in Contemporary Real Clinical Practice in Japan - Observations From the Prospective, Multicenter Kyoto Congestive Heart Failure (KCHF) Registry. Circ J. 2018;82:2811-9. Go to original source... Go to PubMed...
  12. Wright SP, Verouhis D, Gamble G, et al. Factors influencing the length of hospital stay of patients with heart failure. Eur J Heart Fail. 2003;5:201-9. Go to original source... Go to PubMed...
  13. Sud M, Yu B, Wijeysundera HC, et al. Associations Between Short or Long Length of Stay and 30-Day Readmission and Mortality in Hospitalized Patients With Heart Failure. JACC Heart Fail. 2017;5:578-88. Go to original source... Go to PubMed...
  14. Kapoor JR, Kapoor R, Ju C, et al. Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction. JACC Heart Fail. 2016;4:464-72. Go to original source... Go to PubMed...
  15. Drazner MH, Hellkamp AS, Leier CV, et al. Value of Clinician Assessment of Hemodynamics in Advanced Heart Failure: The ESCAPE Trial. Circ Heart Fail. 2008;1:170-7. Go to original source... Go to PubMed...
  16. Fonarow GC, Abraham WT, Albert NM, et al. Factors Identified as Precipitating Hospital Admissions for Heart Failure and Clinical Outcomes: Findings From OPTIMIZE­‑HF. Arch Intern Med. 2008;168:847-54. Go to original source... Go to PubMed...
  17. Omar HR, Guglin M. Longer­‑than­‑average length of stay in acute heart failure: Determinants and outcomes. Herz. 2018;43:131-9. Go to original source... Go to PubMed...
  18. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599-726. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.